-
-
-
-
An intoxicated, violent patient can bring down morale in an ED and turn a shift into havoc faster than any other patient encounter. This issue of ED Legal Letter will outline risk management strategies aimed at reducing both litigation and stress for the EP and nurse.
-
The congenital Marfan syndrome afflicts some 200,000 people in the U.S. Worldwide, the incidence is one in 10,000, or about 700,000 of the planets population.
-
CryoCath Technologies (Montreal, Quebec), a developer of cryotherapy products to treat cardiovascular disease, reached an agreement with Endocare (Irvine, California) to acquire the exclusive and permanent global rights to SurgiFrost, a surgical probe system to ablate cardiac arrhythmias.
-
Edwards Lifesciences (Irvine, California) reported completion early this month of a 20-year follow-up on the effectiveness and durability of its leading aortic pericardial tissue heart valve.
-
Cardiac Science (Irvine, California), a manufacturer of public access defibrillators, said it is now working in conjunction with the American Red Cross (Washington) national organization and local Red Cross chapters across the country to make Powerheart automated external defibrillators (AEDs) available to businesses, government facilities and individuals in their communities.
-
A call to action to increase the awareness, detection and treatment of peripheral arterial disease (PAD) among healthcare professionals was published last month in the Archives of Internal Medicine.
-
S. Lewis Meyer, PhD, has been named president and CEO of Lipid Sciences (Pleasanton, California). He will continue to serve as a director, a position he has held since July 2002. Meyer was president and CEO of Imatron until its acquisition by GE Medical Systems in December 2001.
